BNP and NT-proBNP tests enable labs to obtain accurate diagnostic and risk assessment results for heart failure and acute coronary syndrome. Join Dr. Pete Kavsak as he explains how BNP and NT-proBNP assays are used in today, and the latest IFCC C CB recommendations for the use of natriuretic peptides. He also discusses the debate surrounding Entresto and the use of natriuretic peptides in clinical practice.
Atellica® IM and ADVIA Centaur® NT-proBNP assay not available for sale in the U.S.
Product availability may vary from country to country and is subject to local regulatory requirements.